3 antibody, an anti glypican 3 antibody having a modulated plasma half life and a pharmaceutical composition comprising the antibody as {HEAD ~ an active ingredient}, as well as a method of preparing {TAIL ~ the anti glypican 3 antibody} and the pharmaceutical composition 
3 antibody , an anti glypican 3 antibody having a modulated plasma half life and a pharmaceutical composition comprising the antibody as { HEAD ~ an active ingredient } , as well as a method of preparing { TAIL ~ the anti glypican 3 antibody } and the pharmaceutical composition
OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD HEAD OTH OTH OTH OTH OTH OTH OTH OTH TAIL TAIL TAIL TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH